Bitchute odysee Telegram Feed

LDL “Bad cholesterol” Indicates an Amino Acid Deficiency, 99 Year Old Researcher Says

Fred Kummerow is an emeritus professor of comparative biosciences at the University of Illinois, and at 99 years of age, he is still conducting and publishing research. For over 60 years Professor Kummerow has warned about the dangers of trans fats, even suing the FDA for not removing the GRAS (generally recognized as safe) status on them years after most other countries had banned them. Professor Kummerow has also battled against the standard thinking regarding cholesterol, stating that dietary cholesterol is good for your heart and that there are other factors that contribute to heart disease. In a paper published in 2013 in the American Journal of Cardiovascular Disease, he explained once again that oxidized lipids (and oxidized cholesterol), as is found in overheated polyunsaturated oils like corn and soy, are leading contributing factors to heart disease. In 2014, Professor Kummerow was still going strong at age 99, and has just published a new paper showing that LDL cholesterol is simply a marker for an amino acid deficiency and not the cause of heart disease at all.

Read More

New Alzheimer’s Drugs Continue to Fail Where Coconut Oil Shines

News here in 2014 is reporting that two more Alzheimer drugs have failed during drug trials. Alzheimer's Disease represents a huge market for pharmaceutical companies, as millions of people are suffering from the disease, and the rate is increasing rapidly. Many pharmaceutical companies are trying to develop Alzheimer's drugs and vaccines. However, if we are to truly understand the Alzheimer's epidemic, we need to stop viewing senior citizens as a lucrative market for pharmaceutical products. The most successful drug of all time, Lipitor, is a cholesterol-lowering drug aimed at seniors that at one time out sold all other drugs combined. It is estimated that today one out every four Americans over the age of 55 is now taking statin drugs to artificially lower their body's cholesterol. Unfortunately, there is research pointing to a lack of cholesterol uptake to the brain as being associated with Alzheimer's patients. Therefore, poor dietary advice and excessive pharmaceutical drugs must be considered as a primary cause of Alzheimer's Disease. All across the globe, people are starting to use coconut oil to treat Alzheimer's Disease, and the results have been nothing less than remarkable. In this report we take a look at some of these stories, as well as looking at research linking the high-fat ketogenic diet to curing many diseases such as Alzheimer's.

Read More

Beta-Blockers Killed 800,000 in 5 Years: “Good Medicine” or Mass Murder?

Most people assume that scientific integrity is somehow assured; that there are safeguards along the way, preventing fraudulent research from harming patients. Unfortunately, scientific misconduct has become a very serious and widespread problem that threatens the entire paradigm of science-based medicine—unless changes are made. Again and again, papers assessing the prevalence of scientific fraud and/or the impact this is having shows that the situation is dire and getting worse. In short, we have lost scientific integrity, and without it, “science-based medicine” is just a term without substance. Conflict of interest is another pervasive problem within the research field, and the featured article highlights a case that contains both. Beta-blockers are drugs commonly used in the treatment of high blood pressure and congestive heart failure. They work primarily by blocking the neurotransmitters norepinephrine and epinephrine (adrenaline) from binding to beta receptors, thereby dilating blood vessels, which reduces your heart rate and blood pressure. Until recently, the European Society of Cardiology (ESC) also recommended using beta-blockers in patients undergoing non-cardiac surgery. A recent article in Forbes Magazine highlights how medical guidelines based on questionable science may have resulted in the death of hundreds of thousands of patients in just a few years: “Last summer, British researchers provoked concern when they published a paper raising the possibility that by following an established guideline UK doctors may have caused as many as 10,000 deaths each year,” Larry Husten, editorial director of WebMD professional news, writes. Now, they have gone a step further and published an estimate that the same guideline may have led to the deaths of as many as 800,000 people in Europe over the last five years… The 800,000 deaths are comparable in size to the worst cases of genocide and mass murder in recent history.”

Read More

New Cholesterol Treatment Guidelines Could Double the Number of People on Dangerous Statins—Including Perfectly Healthy People

One in four Americans over the age of 45 currently take a statin drug, despite the fact that there are over 900 studies proving their adverse effects, which run the gamut from muscle problems to increased cancer risk. Now, new treatment guidelines for high cholesterol will likely DOUBLE the number of Americans being prescribed these dangerous drugs, bringing the total to an estimated—and staggering—72 million people! 12 of the 16 panel members of the new guidelines are affiliated with more than 50 different drug companies, many of which have a financial interest in the outcome of this report.

Read More

A Pox on Cholesterol Lowering Drugs: Statins Raise Herpes Zoster (Shingles) Risk

A new study published in the journal Clinical Infectious Diseases reveals an association between statin drug use and increased risk of herpes zoster (shingles). Researchers from St. Michael's Hospital, Ontario, Canada, conducted a population-based retrospective cohort study of Ontario residents 66 years of age or older, with a study period of thirteen years. They matched 494,651 individuals treated with a statin to an equal number of individuals not treated with one. In the main analysis, the rate of herpes zoster was higher among users of statins relative to nonusers of these drugs.

Read More

Dr. Brownstein on New Cholesterol Guidelines: Fugetaboutit

This week, the new guidelines on preventing heart disease were released by the American Heart Association and the American College of Cardiology. The media reported widely about this. Now, for most people, monitoring LDL-cholesterol and total cholesterol levels is not indicated. If your risk of developing cardiac disease is over 7.5% over a ten year period, then statins are recommended. The risk can be calculated by going to the American Heart Association website and plugging in your cholesterol and HDL-cholesterol numbers as well as your age and whether you smoke or not. It is hard for me to believe that this is where modern medicine is at. I guess nobody needs to see a health care professional anymore—just put your numbers in and if you have a 10-year heart attack risk of >7.5%,then you must take a statin for the rest of your life. I have one word for this nonsense: fugetaboutit. People do not get vascular events from a lack of a statin medication. Vascular events occur from a myriad of reasons including eating a poor diet, dehydration, as well as nutrient and hormonal imbalances. Don’t be scared about the media headlines. As you become more educated you will be more comfortable making your health care decisions.

Read More

Cholesterol Numbers Meaningless, but FDA to Approve New Class of Cholesterol-lowering Drugs Anyway

Recently, the latest guidelines (issued by the American Heart Association and the American College of Cardiology) on preventing cardiovascular disease were launched in the US, with a great blare of publicity. The key message was that targets for lowering cholesterol levels are now gone. Don’t worry about cholesterol levels! This is a remarkable U-turn and not only that. What they are saying, in effect, is that lowering LDL is of no use at all. So you might think that the logical next step is that fewer people should be taking statins. Yet weirdly the guidelines now recommend that far more people start to take statins. Perhaps another forty million in the US alone.

Read More

Why the “War” on Saturated Fat Was the Biggest Mistake in the History of Nutrition

The “war” on saturated fat is the biggest mistake in the history of nutrition. As people have reduced their intake of animal fat and cholesterol, many serious diseases have gone up. We are now in the midst of worldwide pandemics of obesity, metabolic syndrome and type II diabetes. Studies conducted in the past few decades conclusively show that neither saturated fat nor dietary cholesterol cause harm in humans. Scientists are now beginning to realize that the entire low-fat dogma was based on flawed studies that have since been thoroughly debunked. Here are 6 graphs that clearly show how incredibly damaging it has been to advise people to reduce their consumption of saturated fat.

Read More

CoQ10 versus Ubiquinol – What You Need to Know, Especially if You Take Statins

Coenzyme Q10 is used for energy production by every cell in your body, and also helps protect against cellular damage from free radicals. CoQ10 is especially important if you’re taking a statin drug as statins deplete your body of CoQ10, thereby speeding up progression of heart disease. Ubiquinol is the reduced form of CoQ10 – the effective form your body naturally uses to transfer free electrons – and research shows that this reduced form is superior for your health in a number of ways, primarily due to its superior bioavailability if you’re over 25. CoQ10 has been available for many decades, but the reduced version, ubiquinol, has only been commercially available for about six years. Prior to that it could only be made for research studies. There are well over 100 studies supporting its use and demonstrating its many health benefits, including its beneficial effect on statin-induced myalgia and other diseases rooted in mitochondrial dysfunction. Studies have demonstrated that ubiquinol has a positive effect on: inflammatory processes, septic shock (which is also associated with mitochondrial dysfunction), cardiac arrest and stroke recovery, and periodontal disease (including gingivitis and dry mouth).

Read More

ABC Australia Exposes Cholesterol-lowering Statin Drug Scam and Pharmaceutical Criminal Activity

ABC News in Australia has done an incredible investigative report on cholesterol-lowering statin drugs, daring to expose organized crime in the pharmaceutical industry in the U.S. This is an area where no mainstream media outlet in the USA dares to go, due to the influence of the pharmaceutical industry. In this excellent investigative documentary, cardiologists are interviewed to reveal the fraud of cholesterol-lowering statin drugs, and the criminal activity that has allowed this class of drug to become the best-selling class of drugs all-time. Some of the top cardiologists in the U.S. have stated that there is not one single study showing that people who take statins will actually live longer. This fraud is now coming out into the open. After ABC Australia aired Part 1, The Heart of the Matter, last week, Australia’s top medicine safety expert, Emily Banks, urged ABC not to air the follow-up, because it might encourage people to go off their anti-cholesterol statin drugs. “If people stop using their statins . . . it’s very likely that it will result in death.” But those scare tactics and attempts at censorship failed, and below is Part 2 as it was aired in Australia, and is now available for the world to watch. If you or someone you know are prescribed a cholesterol-lowering statin drug, you would do well to invest 30 minutes of your time to watch this investigative report. You are not likely to learn this information from your doctor, and it could literally change your life.

Read More